 ?您的位置：對(duì)照品 > 標(biāo)準(zhǔn)物質(zhì) > 質(zhì)控品 > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：G797450 |
| 產(chǎn)品名稱：GSK 1059615 Sodium Salt Hydrate |
| 產(chǎn)品CAS：1356195-42-0 |
| 規(guī)格含量：100mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
G797450 |
| 名稱: |
GSK 1059615 Sodium Salt Hydrate |
| 別名: |
(5Z)-5-[[4-(4-Pyridinyl)-6-quinolinyl]methylene]-2,4-thiazolidinedione Sodium Salt Hydrate; |
| CAS號(hào): |
1356195-42-0 |
| 參考CAS號(hào): |
Free acid/Anhydrous: 958852-01-2 |
| 分子式: |
C??H??N?NaO?S•xH?O |
| 外觀: |
淡黃色固體 |
| 熔點(diǎn): |
>290°C (dec.) |
| 分子量: |
355.35 |
| 儲(chǔ)存: |
冰箱 |
| 溶解度: |
DMSO, Methanol |
| 種類: |
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
GSK 1059615 is a potent inhibitor of PI 3-kinase α (PI3Kα). GSK 1059615 inhibits proliferation in BT474 cells and attenuates MAPK signaling. |
| 參考文獻(xiàn) |
|
|
|
|
|
|
